TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
ProPharma Group Sweden AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
85,688
|
95,804
|
97,444 |
| Financial expenses |
1,473
|
1,446
|
14 |
| Earnings before taxes |
-20,565
|
-3,660
|
-4,982 |
| EBITDA |
-19,017
|
-4,254
|
-4,794 |
| Total assets |
50,002
|
66,562
|
52,606 |
| Current assets |
49,590
|
66,036
|
51,936 |
| Current liabilities |
32,427
|
44,417
|
26,801 |
| Equity capital |
17,575
|
19,505
|
22,505 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
55
|
57
|
65 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
35.1%
|
29.3%
|
42.8% |
| Turnover per employee |
1,558
|
1,681
|
1,499 |
| Profit as a percentage of turnover |
-24.0%
|
-3.8%
|
-5.1% |
| Return on assets (ROA) |
-38.2%
|
-3.3%
|
-9.4% |
| Current ratio |
152.9%
|
148.7%
|
193.8% |
| Return on equity (ROE) |
-117.0%
|
-18.8%
|
-22.1% |
| Change turnover |
-10,116
|
-1,640
|
631 |
| Change turnover % |
-11%
|
-2%
|
1% |
| Chg. No. of employees |
-2
|
-8
|
8 |
| Chg. No. of employees % |
-4%
|
-12%
|
14% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.